TScan Therapeutics Growth Metrics (2020-2025) | TCRX

Growth Metrics Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) 181,596.0048,477.00-14439.00-92.0016,385.00-10494.0014,290.00-40588.00-14373.0030,638.00-515081.00-558279.00-247313.00-522443.00387,320.00510,795.00163,423.00
EBITDA Margin Growth (3y) 183,607.0068,622.00-515231.00-598959.00-245302.00-502298.00-113472.00-88071.00-98263.00
EBITDA Margin Growth (5y) 99,717.00
EBITDA Margin (QoQ) 149,037.0059,176.001,566.00-28183.0015,918.00-3740.0015,913.00-11707.00-10960.0021,043.00-38965.0014,508.0034,051.00-524676.00-82162.00325,473.00-241078.00385,086.0041,314.00-21899.00
EBIT Margin Growth (1y) 181,596.0048,477.00-14439.00-92.0016,385.00-10494.0014,290.00-40588.00-14373.0030,638.00-515081.00-558279.00-247313.00-522443.00387,320.00510,795.00163,423.00
EBIT Margin Growth (3y) 183,607.0068,622.00-515231.00-598959.00-245302.00-502298.00-113472.00-88071.00-98263.00
EBIT Margin Growth (5y) 99,717.00
EBIT Margin (QoQ) 149,037.0059,176.001,566.00-28183.0015,918.00-3740.0015,913.00-11707.00-10960.0021,043.00-38965.0014,508.0034,051.00-524676.00-82162.00325,473.00-241078.00385,086.0041,314.00-21899.00
EBT Margin Growth (1y) 181,574.0048,447.00-14446.00258.0017,362.00-10740.0014,577.00-39160.00-10859.0033,296.00-493642.00-514308.00-225746.00-494892.00375,349.00470,560.00142,695.00
EBT Margin Growth (3y) 188,077.0071,003.00-493511.00-553211.00-219242.00-472335.00-103716.00-82909.00-93909.00
EBT Margin Growth (5y) 105,027.00
EBT Margin (QoQ) 149,040.0059,168.001,554.00-28189.0015,913.00-3724.0016,258.00-11084.00-12189.0021,593.00-37480.0017,218.0031,965.00-505345.00-58146.00305,781.00-237181.00364,895.0037,065.00-22084.00
Enterprise Value Growth (1y) -363.93%-15.92%-18.27%24.69%25.64%32.11%-66.27%-56.89%-60.00%-70.26%-42.54%-25.85%-51.06%-54.62%26.75%31.97%
Enterprise Value Growth (3y) -76.73%-10.24%-41.00%-14.14%-21.59%-21.35%-20.18%-10.34%
Enterprise Value (QoQ) -249.23%12.60%-71.67%11.47%12.74%10.82%-9.32%12.58%20.34%-118.44%-3.15%10.85%15.24%-82.87%8.92%-7.00%13.24%13.37%15.41%
FCF Margin Growth (1y) 185,844.0051,742.00-4652.0013,704.008,270.001,955.0026,259.00-33666.0068,791.0022,569.00-487429.00-434065.00-296174.00-391956.00349,356.00393,046.00144,237.00
FCF Margin Growth (3y) 262,906.0076,266.00-465821.00-454027.00-219112.00-367431.00-111813.00-74685.00-83145.00
FCF Margin Growth (5y) 110,969.00
FCF Margin (QoQ) 136,057.0046,154.0012,393.00-8760.001,955.00-10239.0030,748.00-14194.00-4361.0014,066.00-29178.0088,264.00-50583.00-495932.0024,186.00226,155.00-146365.00245,380.0067,876.00-22654.00
Interest Coverage Ratio Growth (1y) 69.44%-31.05%-37.51%-41.09%-35.12%-86.81%-63.19%-56.56%-55.66%
Interest Coverage Ratio Growth (3y) 13.70%
Interest Coverage Ratio (QoQ) 76.81%-24.38%-6.76%0.77%0.53%-30.51%-9.54%4.97%-37.51%-14.01%-5.08%5.51%
Net Margin Growth (1y) 181,574.0048,447.00-14446.00258.0017,362.00-10740.0014,577.00-39160.00-10859.0033,296.00-493642.00-514308.00-225746.00-494892.00375,349.00470,560.00142,695.00
Net Margin Growth (3y) 188,077.0071,003.00-493511.00-553211.00-219242.00-472335.00-103716.00-82909.00-93909.00
Net Margin Growth (5y) 105,027.00
Net Margin (QoQ) 149,040.0059,168.001,554.00-28189.0015,913.00-3724.0016,258.00-11084.00-12189.0021,593.00-37480.0017,218.0031,965.00-505345.00-58146.00305,781.00-237181.00364,895.0037,065.00-22084.00
Operating Margin Growth (1y) 181,596.0048,477.00-14439.00-92.0016,385.00-10494.0014,290.00-40588.00-14373.0030,638.00-515081.00-558279.00-247313.00-522443.00387,320.00510,795.00163,423.00
Operating Margin Growth (3y) 183,607.0068,622.00-515231.00-598959.00-245302.00-502298.00-113472.00-88071.00-98263.00
Operating Margin Growth (5y) 99,717.00
Operating Margin (QoQ) 149,037.0059,176.001,566.00-28183.0015,918.00-3740.0015,913.00-11707.00-10960.0021,043.00-38965.0014,508.0034,051.00-524676.00-82162.00325,473.00-241078.00385,086.0041,314.00-21899.00
Return on Assets Growth (1y) -14.00-12.00-7.005.0010.005.001.00-1.00-2.00-3.001.00-9.00-20.00
Return on Assets Growth (3y) -6.00-10.00-5.00-5.00-12.00
Return on Assets (QoQ) 0.00-7.00-6.00-1.002.00-3.006.004.00-3.00-6.004.003.00-4.00-2.00-6.00-7.00
Return on Capital Employed Growth (1y) -14.00-13.00-7.004.0010.003.00-3.00-2.00-2.00-5.002.00-9.00-23.00
Return on Capital Employed Growth (3y) -7.00-14.00-8.00-8.00-15.00
Return on Capital Employed (QoQ) 1.00-8.00-7.00-1.003.00-2.003.006.00-4.00-8.004.006.00-6.00-2.00-7.00-8.00
Return on Equity Growth (1y) -105.0024.00-32.00-45.00-17.001.005.0011.006.003.002.0013.00-15.00-42.00
Return on Equity Growth (3y) -116.0028.00-25.00-21.00-26.00-39.00
Return on Equity (QoQ) -135.0045.00-8.00-7.00-5.00-12.00-21.0021.0012.00-7.00-15.0015.009.00-8.00-4.00-12.00-18.00
Return on Sales Growth (1y) 1,816.00484.00-144.003.00174.00-107.00146.00-392.00-109.00333.00-4936.00-5143.00-2257.00-4949.003,753.004,706.001,427.00
Return on Sales Growth (3y) 1,881.00710.00-4935.00-5532.00-2192.00-4723.00-1037.00-829.00-939.00
Return on Sales Growth (5y) 1,050.00
Return on Sales (QoQ) 1,490.00592.0016.00-282.00159.00-37.00163.00-111.00-122.00216.00-375.00172.00320.00-5053.00-581.003,058.00-2372.003,649.00371.00-221.00